Related Experiment Video
Updated: Apr 20, 2026

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
Published on: November 22, 2024
Molecular Basis of Pterygium Development
Eduardo Cárdenas-Cantú1, Judith Zavala1, Jorge Valenzuela1
1a Ophthalmology Research Chair, School of Medicine and Health Sciences, Tecnologico de Monterrey , Monterrey , Mexico and.
Abstract:
Pterygium pathogenesis is mainly related to UV light exposure. However, the exact mechanisms by which it is formed have not been elucidated. Clinical advances in surgical treatment use conjunctival autografts and amniotic membranes in combination with adjuvant therapies, including mitomycin C, β-radiation, and 5-fluoroacil, to reduce recurrence. Several studies aim to unveil the molecular mechanisms underlying pterygium growth and proliferation. They demonstrate the role of different factors, such as viruses, oxidative stress, DNA methylation, apoptotic and oncogenic proteins, loss of heterozygosity, microsatellite instability, inflammatory mediators, extracellular matrix modulators, lymphangiogenesis, cell epithelial-mesenchymal transition, and alterations in cholesterol metabolism in pterygium development. Understanding the molecular basis of pterygium provides new potential therapeutic targets for its prevention and elimination. This review focuses on providing a broad overview of what is currently known regarding molecular mechanisms of pterygium pathogenesis.
Insights
Pterygium, a growth on the eye, is linked to UV exposure. This review explores the molecular factors driving pterygium development, offering insights into potential new treatments.
Area of Science:
- Ophthalmology
- Molecular Biology
- Genetics
Background:
- Pterygium pathogenesis is primarily associated with ultraviolet (UV) light exposure, though precise mechanisms remain unclear.
- Current surgical treatments for pterygium involve conjunctival autografts and amniotic membranes, often with adjuvant therapies like mitomycin C to minimize recurrence.
Purpose of the Study:
- To provide a comprehensive overview of the current understanding of molecular mechanisms involved in pterygium pathogenesis.
- To identify potential therapeutic targets for pterygium prevention and treatment based on its molecular underpinnings.
Main Methods:
- This review synthesizes findings from various studies investigating pterygium growth and proliferation.
- It examines molecular factors implicated in pterygium development, including genetic and cellular processes.
Main Results:
- Multiple factors contribute to pterygium development, including viral infections, oxidative stress, DNA methylation, and altered cholesterol metabolism.
- Key processes involved are loss of heterozygosity, microsatellite instability, inflammatory responses, extracellular matrix modulation, lymphangiogenesis, and epithelial-mesenchymal transition.
Conclusions:
- Understanding the molecular basis of pterygium is crucial for developing novel therapeutic strategies.
- Identifying these molecular targets may lead to more effective methods for preventing and eliminating pterygium growth.
Related Concept Videos
Abnormal Proliferation
Hedgehog Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Long-patch Base Excision Repair
Mechanism of Angiogenesis

